JOLENE MUSCAT MD.

Department:
UNIV.ASSOC.IN OBSTETRICS&GYNECOLOGY

Clinical Practice Began:
2008

Gender:
Female

Primary Medical Conditions Treated:

AMNIOCENTESIS
DIABETES IN PREGNANCY
FETAL ULTRASOUND
GYNECOLOGICAL CARE
GYNECOLOGY
HIGH RISK INFANTS
HIGH RISK OBSTETRICS
OBSTETRICS
PREGNANCY INDUCED HYPERTENSION
PREGNANCY WITH HYPOTHYROIDISM (HYPOTHYROIDISM DURING PREGNANCY)
PRENATAL CARE
PRENATAL DIAGNOSIS (AMNIOCENTESIS)
PRETERM LABOR
ULTRASOUND
WOMEN'S HEALTH

Education and Training

Medical School:
University at Buffalo, School of Medicine and Biomedical Sciences, NY

Residency:
Winthrop University Hospital, NY

Academic

Year Appointed at Stony Brook:
2008

Honors, Awards and Grants:
Member of the American Medical Association, Medical Society of the State of New York and the American College of Obstetricians and Gynecologists (Jr. Fellow). Dr. Muscat graduated Cum Laude from the University at Buffalo School of Medicine and Biomedical Sciences in 2004.

Academic Rank:
Clinical Instructor

Teaching Activity:
Obstetrics & Gynecology

Insurance Plans

MEDICAID
MEDICARE

Practice Sites

My Notes

There are 600 + physicians and other health care providers practicing within 18 different clinical entities, or specialty groups that are affiliated with Stony Brook University Physicians (SBU Physicians). Together, these providers offer patients of all ages a comprehensive range of high quality medical services, from primary care to advanced specialty care. The physicians and health care professionals affiliated with SBU Physicians are committed to excellence in service and leadership in clinical care. In their capacity as faculty of the Stony Brook University School of Medicine, they also educate medical students, interns, residents and fellows in many specialties and sub-specialties, and engage in research and clinical trials that help to advance the science of medicine.

My Articles

1. Evans JF, Amorin L, Muscat JC, Ventimiglia J, Ragolia L, Maulik D. Smad 1, Neuropilin (Nrp-1) and Angiopoietin-2 (Ang-2) are Down-regulated in IUGR Placenta Possibly Leading to Deficient Angiogenesis. Submitted for publication 2007.

2. Harvey BG, Maroni J, O'Donoghue KA, Chu KW, Muscat JC, Pippo AL, Wright CE, Kaner RJ, Hollmann C, Wisnivesky JP, Kessler PD, Rasmussen HS, Rosengart TK and Crystal RG. Safety of Local Delivery of Low and Intermediate Dose Adenovirus Gene Transfer Vectors to Individuals with a Spectrum of Morbid Conditions. Human Gene Therapy 13(1):15-36, 2002.

3. Crystal RG, Harvey BG, Wisnivesky JP, O'Donoghue KA, Chu KW, Maroni J, Muscat JC, Pippo AL, Wright CE, Kaner RJ, Leopold PL, Kessler PD, Rasmussen HS, Rosengart TK, Hollmann C. Analysis of Risk Factors for Local Delivery of Low and Intermediate Dose Adenovirus Gene Transfer Vectors to Individuals with a Spectrum of Comorbid Conditions. Human Gene Therapy 13(1):65-100, 2002.